EDITORIAL SECTION
-
STRATEGY
Smarter Pharma
Quality management systems QMS are the backbone of pharmaceutical manufacturing ensuring safe products
-
RESEARCH DEVELOPMENT
Cytiva Laboratory capsule filters
Our singleuse selfcontained filtration solution
-
CLINICAL TRIALS
Why Clinical Trials Need Digital Endpoints
According Citeline the average success rate for bringing a Phase candidate to market has dropped to an alltime low of just
-
MANUFACTURING
Ensuring Quality and Compliance in Biopharma
Ensuring quality and regulatory compliance in the biopharmaceutical industry is critical to safeguarding product safety and efficacy
-
Information Technology
The Cost of Bad Data
Modern pharmaceutical research generates an unprecedented volume of information Data from genomic sequencing
-
Biopharma
Reimagining Global Biomanufacturing Capacity with Continuous and Modular Systems
Biotechnology is fueling the ongoing expansion of the global market for a broad array of goods
-
EXPERT Talk
From Compliance to Competitive Advantage
Compliance gets you through an audit Resilience gets medicines to patients on the day something unexpected happens The DSCSAs enhanced requirements took effect November but real interoperability required three more rounds of accommodation phased implementation with the smalldispenser
Advisory Board
KNOWLEDGE BANK
-
Articles
Top 10 Pharmaceutical Blogs and Publications in Europe
The pharmaceutical industry in Europe operates as one of the worlds most developed and firmly controlled sectors The maintenance of present industry trends alongside research and policies and innovations represents a key requirement for serving professionals within this field The key to industrial progress depends on trustworthy pharmaceutical research obtained through industryleading blogs alongs...
Building Patient-Centric Clinical Trials: Technologies, Strategies, and Regulatory Considerations
Patientcentricity in clinical trials represents a crucial cultural and operational transformation in the development and evaluation of new treatments The patient experience has evolved from a secondary consideration to a central priority in trial design driven by
The Role of Biosimilars in the European Pharma Market: Advancements, Challenges, and Future Perspectives
The European pharmaceutical landscape has undergone remarkable transformations in recent years with the emergence of biosimilars playing a pivotal role in reshaping the industry Before delving into the intricacies of biosimilars
Efficiency in Bioprocessing: Unveiling Upstream and Downstream Operations
Bioprocessing plays a crucial role in the pharmaceutical biotechnology and healthcare industries ensuring the efficient production of biologics vaccines and other biobased products
B2B Pharma Webinars: Driving Regulatory Insights for Decision-Makers
The regulatory intelligence in the modern dynamic pharmaceutical ecosystem cannot be just an office role any longer it is a strategic necessity With the changing world guidelines and digital transformation reallife evidences needed and crossborder compliance frameworks the decisionmakers have to keep pace with the incessant change in regulations
Why Biopharma is switching to Single-Use Systems: Cost, Quality, and Flexibility
Singleuse biopharma systems have replaced traditional stainlesssteel systems in the biopharmaceutical industry because of a major industry transformation What factors lead the market toward this direction Major factors that drive the industry involve establishing savings from singleuse equipment in pharmaceutical applications
-
Techno Trends
FDA Grants Breakthrough Therapy Designation to Calico's Fosigotifator
Calico Life Sciences LLC has announced that the US Food and Drug Administration FDA has granted Breakthrough Therapy Designation to fosigotifator for the treatment of Vanishing White Matter disease a rare and progressive neurological disorder with no approved therapies
-
Projects
Johnson & Johnson Invests $1B to Expand U.S. Vision Manufacturing & Distribution
Johnson Johnson has announced an investment of more than billion to expand its Vision manufacturing operations in Jacksonville Florida The project is designed to increase domestic manufacturing packaging and distribution capacity for the company
-
Research Insights
A genomic-led strategy to anticipate drug safety effects
Safetyrelated issues account for approximately of failures in new drug discovery programs On top of that many are discovered during postmarketing surveillance
-
whitepaper
Placing the Right Bets: Defining Tailored Investment Strategies for Pharma Launch
Pharmaceutical launches have become significantly harder to execute successfully As IQVIAs new white paper highlights median six month cumulative sales for innovative launches have declined by compared with pre levels reflecting shrinking market opportunities
TOP ARTICLES
-
1
Building Patient-Centric Clinical Trials: Technologies, Strategies, and Regulatory Considerations
Dr. Kalpana Katiyar
Ms. Shreeya Arora
Patient-centric clinical studies aim to improve the participant experience, foster diversity, enhance retention, and increase data quality. Advancements in decentralized trial models, digital health t...
-
2
The Role of Biosimilars in the European Pharma Market: Advancements, Challenges, and Future Perspectives
Kate Williamson
This article explores the evolving role of biosimilars in the European pharmaceutical market, focusing on advancements, challenges, and future perspectives. Biosimilars, mimicking existing biologics,...
-
3
Efficiency in Bioprocessing: Unveiling Upstream and Downstream Operations
Kate Williamson
Efficiency in Bioprocessing: Unveiling Upstream and Downstream Operations explores the key aspects of bioprocessing efficiency, covering upstream and downstream operations, integration strategies, fut...
-
4
B2B Pharma Webinars: Driving Regulatory Insights for Decision-Makers
Kate Williamson
Pharma webinars in B2B transform the intelligence of decision-makers with the benefits of expert-led content, compliance and strategic advice. These electronic platforms lead to better regulatory cong...
-
5
Why Biopharma is switching to Single-Use Systems: Cost, Quality, and Flexibility
Sarah Richards
Single-use systems in the biopharmaceutical field are gaining popularity because they deliver improved quality control features as well as enhanced flexibility combined with cost reductions. Single-us...
press releases Read more...
CREATE Medicines Expands Targeted In Vivo CAR Platform Through Strategic Research Collaboration and Exclusive License Agreement with Monash University
CREATE Medicines Inc CREATE a clinicalstage biotechnology company pioneering in vivo immune programming today announced a strategic research collaboration with Australias Monash University
Relation Announces Expanded Collaboration with GSK
Relation today announced a strategic research collaboration with GSK focused on generating largescale human cellular perturbation data and deploying them into models including MORGAN
Resilience and Lilly Invest $750 Million to Increase U.S.-Manufactured Medicine Supply
Resilience a technologyforward contract development and manufacturing organization dedicated to broadening access to complex medicines today announced it has expanded its strategic partnership with Eli Lilly and Company
MiRecule Announces Strategic Collaboration with EMS Group Company Rio Biopharma to Advance Targeted Delivery of RNA Therapeutics
MiRecule Inc a biotechnology company developing nextgeneration RNA therapeutics for rare genetic diseases today announced a strategic research collaboration with Rio Biofarma Brasil Ltda RBBL
Events Read more...
03 - 04
Aug 2026Clinical Pharmacology and Toxicology 2026
Dubai, UAE
11 - 12
Aug 2026Medical Device Safety Monitoring and Reporting
San Diego, CA, USA
19 - 21
Aug 2026ISPE Conference & Exhibition 2026
Suntec Singapore
20 - 21
Aug 2026Pharmaceutical Formulations 2026
London, UK
20 - 21
Aug 2026Novel Drug Delivery Systems 2026
London, UK
20 - 21
Aug 2026Advanced Clinical Research 2026
London, UK
25 - 27
Aug 2026CPHI Korea 2026
COEX, Seoul, Korea
26 - 27
Aug 2026BIOMEDevice 2026
Boston Convention & Exhibition...
LATEST NEWS Read more...
Novo Nordisk Updates on ZEUS Phase 3 Trial of Ziltivekimab
Novo Nordisk has announced headline results from the Phase ZEUS cardiovascular outcomes trial evaluating ziltivekimab in people with atherosclerotic cardiovascular disease ASCVD chronic kidney disease CKD and inflammation
FDA and EMA Accept Applications for Polpharma Biologics' Vedolizumab Biosimilar PB016
Polpharma Biologics has announced that the US Food and Drug Administration FDA and the European Medicines Agency EMA have accepted for review its Biologics License Application BLA
Abivax Advances NDA Plans for Obefazimod Following Positive FDA Meeting
Abivax has completed a positive preNew Drug Application NDA meeting with the US Food and Drug Administration FDA for obefazimod its investigational treatment for adults with moderately to severely active ulcerative colitis UC
Iksuda Receives FDA Clearance to Begin Phase I Trial of IKS04
Iksuda Therapeutics has received Investigational New Drug IND clearance from the US Food and Drug Administration FDA for IKS allowing the company to begin a Phase I clinical trial in patients with gastrointestinal GI cancers
FDA Grants Orphan Drug Designation to Enzomenib for Acute Lymphoblastic Leukaemia
Sumitomo Pharma America has announced that the US Food and Drug Administration FDA has granted Orphan Drug Designation to enzomenib DSP for the treatment of patients with acute lymphoblastic leukaemia ALL
Allogene Therapeutics Gains FDA RMAT and Fast Track Status for Cema-Cel in First-Line Large B-Cell Lymphoma
Allogene Therapeutics has received Regenerative Medicine Advanced Therapy RMAT and Fast Track designations from the US Food and Drug Administration FDA for its investigational allogeneic CAR T therapy





